| 1 |
论文 |
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies |
Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, Pham PT, Mulvihill MS, Ziaei F, Zhang H, Su B, Zhi X, Quesenberry CP, Habel LA, Deng Q, Wang Z, Zhou J, Li H, Huang MC, Yeh CC, Segal MR, Ray MR, Jones KD, Raz DJ, Xu Z, Jahan TM, Berryman D, He B, Mann MJ,Jablons DM |
Lancet |
2012;379(9818):823-832 |
| 2 |
论文 |
Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer |
Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D, Wang Z, Zhu Z, Deng Q, Xiong X, Shao W, Shi X, He J |
Journal of Clinical Oncology |
2015;33(8):861-869 |
| 3 |
论文 |
Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas |
Wu K, Zhang X, Li F, Xiao D, Hou Y, Zhu S, Liu D, Ye X, Ye M, Yang J, Shao L, Pan H, Lu N, Yu Y, Liu L, Li J, Huang L, Tang H, Deng Q, Zheng Y, Peng L, Liu G, Gu X, He P, Gu Y, Lin W, He H, Xie G, Liang H, An N, Wang H, Teixeira M, Vieira J, Liang W, ZhaoX, Peng Z, Mu F, Zhang X, Xu X, Yang H, Kristiansen K, Wang J, Zhong N, Wang J, Pan-Hammarström Q, He J |
Nature Communications |
2015;6:10131 |
| 4 |
论文 |
A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer |
Liu B, Yang L, Huang B, Cheng M, Wang H, Li Y, Huang D, Zheng J, Li Q, Zhang X, Ji W, Zhou Y, Lu J |
American Journal of Human Genetics |
2012;91(2):384-390 |
| 5 |
论文 |
Sequence Variation in Mature MicroRNA-499 Confers Unfavorable Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy |
Qiu F, Yang L, Ling X, Yang R, Yang X, Zhang L, Fang W, Xie C, Huang D, Zhou Y, Lu J |
Clinical Cancer Research |
2015;21(7):1602-1613 |
| 6 |
论文 |
MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells |
Du B, Wang Z, Zhang X, Feng S, Wang G, He J, Zhang B |
PLoS One |
2014;9(2):e88022 |
| 7 |
论文 |
MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells |
Feng S, Cong S, Zhang X, Bao X, Wang W, Li H, Wang Z, Wang G, Xu J, Du B, Qu D, Xiong W, Yin M, Ren X, Wang F, He J, Zhang B |
Nucleic Acids Research |
2011;39(15):6669-6678 |
| 8 |
论文 |
Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells |
Ren XS, Yin MH, Zhang X, Wang Z, Feng SP, Wang GX, Luo YJ, Liang PZ, Yang XQ, He JX, Zhang BL |
Cancer Letters |
2014;344(2):195-203 |
| 9 |
论文 |
Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation |
Yin M, Ren X, Zhang X, Luo Y, Wang G, Huang K, Feng S, Bao X, Huang K, He X, Liang P, Wang Z, Tang H, He J, Zhang B |
Oncogene |
2015;34(6):691-703 |
| 10 |
论文 |
The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters |
Bao X, Wu H, Zhu X, Guo X, Hutchins AP, Luo Z, Song H, Chen Y, Lai K, Yin M, Xu L, Zhou L, Chen J, Wang D, Qin B, Frampton J, Tse HF, Pei D, Wang H, Zhang B, |
Cell Research |
2015;25(1):80-92 |
| 11 |
论文 |
MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer |
Zhang X, Xiao D, Wang Z, Zou Y, Huang L, Lin W, Deng Q, Pan H, Zhou J, Liang C, He J |
Molecular Cancer Research |
2014;12(11):1535-1546 |
| 12 |
论文 |
Oncogenic role of long noncoding RNA AF118081 in anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide-transformed 16HBE cells |
Yang Q, Zhang S, Liu H, Wu J, Xu E, Peng B, Jiang Y |
Toxicology Letters |
2014;229(3):430-439 |
| 13 |
论文 |
Sequence Variation in Mature MicroRNA-499 Confers Unfavorable Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy |
Qiu F, Yang L, Ling X, Yang R, Yang X, Zhang L, Fang W, Xie C, Huang D, Zhou Y, Lu J |
Clinical Cancer Research |
2015;21(7):1602-1613 |
| 14 |
论文 |
Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages |
Zhou JX, Yang H, Deng Q, Gu X, He P, Lin Y, Zhao M, Jiang J, Chen H, Lin Y, Yin W, Mo L, He J |
Annals of Oncology |
2013;24(5):1319-1325 |
| 15 |
论文 |
Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD) |
Qiu Y, Peng GL, Liu QC, Li FL, Zou XS, He JX |
Cancer Letters |
2012;316(1):31-38. |
